Emergent BioSolutions Inc. (EBS) › Operating IncomeEmergent BioSolutions Inc. (EBS) — Operating IncomeAnnual figures by period end, from SEC filings.2009-12-31: $40.15M2010-12-31: $73.56M2011-12-31: $32.10M2012-12-31: $29.97M2013-12-31: $42.80M2014-12-31: $89.19M2015-12-31: $141.51M2016-12-31: $105.50M2017-12-31: $124.30M2018-12-31: $89.80M2019-12-31: $114.10M2020-12-31: $438.50M2021-12-31: $341.40M2022-12-31: -$170.00M2023-12-31: -$726.40M2024-12-31: -$108.70M2025-12-31: $100.10M$100.10M2009-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$100.10M—2026-02-27From 2025-01-012024-12-31-$108.70M—2026-02-27From 2024-01-012023-12-31-$726.40M—2026-02-27From 2023-01-012022-12-31-$170.00M-149.8%2025-03-04From 2022-01-012021-12-31$341.40M-22.1%2024-03-08From 2021-01-012020-12-31$438.50M+284.3%2023-12-11From 2020-01-012019-12-31$114.10M+27.1%2022-02-25From 2019-01-012018-12-31$89.80M-27.8%2021-02-19From 2018-01-012017-12-31$124.30M+17.8%2020-02-25From 2017-01-012016-12-31$105.50M-25.4%2019-02-22From 2016-01-012015-12-31$141.51M+58.7%2018-02-23From 2015-01-012014-12-31$89.19M+108.4%2017-02-28From 2014-01-012013-12-31$42.80M+42.8%2016-02-29From 2013-01-012012-12-31$29.97M-6.6%2015-03-09From 2012-01-012011-12-31$32.10M-56.4%2014-03-10From 2011-01-012010-12-31$73.56M+83.2%2013-03-08From 2010-01-012009-12-31$40.15M—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)